RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in RedHill Biopharma Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q1 2023
- Shares held
- 349.2K
- +55.5K (+18.9%) vs. Q1 2023
- Total value
- $419.2K
- −$781.7K (−65.1%) vs. Q1 2023
- New holders
- 6
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $270.0K |
| Q1 2026 | 16 | $386.5K |
| Q4 2025 | 17 | $514.5K |
| Q3 2025 | 14 | $51.2K |
| Q2 2025 | 12 | $37.9K |
| Q1 2025 | 12 | $80.5K |
| Q4 2024 | 11 | $103.5K |
| Q3 2024 | 11 | $48.8K |
| Q2 2024 | 18 | $719.7K |
| Q1 2024 | 17 | $1.40M |
| Q4 2023 | 19 | $449.2K |
| Q3 2023 | 19 | $781.9K |
| Q2 2023 | 21 | $419.2K |
| Q1 2023 | 20 | $1.20M |
| Q4 2022 | 41 | $1.51M |
| Q3 2022 | 43 | $1.46M |
| Q2 2022 | 48 | $3.89M |
| Q1 2022 | 49 | $11.9M |
| Q4 2021 | 57 | $12.5M |
| Q3 2021 | 61 | $24.5M |
| Q2 2021 | 55 | $49.1M |
| Q1 2021 | 64 | $77.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 142 | $0 | 0.00% | +25+21.4% | Added |
| Signaturefd, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 23 | $28 | 0.00% | −25−52.1% | Reduced |
| BDO Wealth Advisors, LLC | 25 | $30 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 7 | $32 | 0.00% | −300−97.7% | Reduced |
| Bank of America Corp | 32 | $38 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 77 | $93 | 0.00% | +69+862.5% | Added |
| Advisor Group Holdings, Inc. | 116 | $139 | 0.00% | +12+11.5% | Added |
| Steward Partners Investment Advisory, LLC | 125 | $150 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 574 | $689 | 0.00% | −1,156−66.8% | Reduced |
| Morgan Stanley | 601 | $721 | 0.00% | +175+41.1% | Added |
| Group One Trading, L.P. | 629 | $761 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,075 | $1.26K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 3,014 | $3.65K | 0.00% | +3,014 | New |
| Federation des caisses Desjardins du Quebec | 4,402 | $5.28K | 0.00% | −390−8.1% | Reduced |
| We Are One Seven, LLC | 10,750 | $12.9K | 0.00% | +10,750 | New |
| Virtu Financial LLC | 10,728 | $13.0K | 0.00% | +10,728 | New |
| Two Sigma Securities, LLC | 13,149 | $15.8K | 0.00% | +13,149 | New |
| Citadel Advisors LLC | 15,729 | $19.0K | 0.00% | +15,729 | New |
| Cowen and Company, LLC | 288,000 | $345.6K | 0.03% | +288,000 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −260,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −22,943−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,275−100.0% | Sold out |
| Atticus Wealth Management, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1−100.0% | Sold out |